Sun Pharma

Mumbai, India Founded: 1983 • Age: 43 yrs
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
Request Access

About Sun Pharma

Sun Pharma is a company based in Mumbai (India) founded in 1983 by Dilip Shanghvi.. The company has 25,870 employees as of March 31, 2024. Sun Pharma has completed 17 acquisitions, including Biosynthesis, Caraco Pharmaceutical Laboratories and Chattem Chemicals.

  • Headquarter Mumbai, India
  • Employees 25870 as on 31 Mar, 2024
  • Founders Dilip Shanghvi
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sun Pharmaceutical Industries Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $6.09 B (USD)
    8.96
    as on Mar 31, 2024
  • Net Profit
    $1.28 B (USD)
    14.12
    as on Mar 31, 2024
  • EBITDA
    $1.75 B (USD)
    23.83
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    25870

    as on Mar 31, 2024

  • Investments & Acquisitions
    Biosynthesis

    & 16 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sun Pharma

Sun Pharma is a publicly listed company on the NSE with ticker symbol SUNPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: SUNPHARMA . Sector: Health technology · India
People of Sun Pharma
Headcount 10000+
Employee Profiles 139
Board Members and Advisors 4
Employee Profiles
People
Abhimanyu Singh
Country Manager
People
Parth Desai
Manager I- Bd&l And Portfolio Management
People
Mandar Kulkarni
GM - Warehouse And Logistics
People
Sumit Kumar
Production Scheduling

Unlock access to complete

Board Members and Advisors
people
Rama Bijapurkar
Independent Director
people
Rolf Hoffmann
Independent Director
people
Gautam Doshi
Independent Director
people
Pawan Goenka
Lead Independent Director

Unlock access to complete

Funding Insights of Sun Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Sun Pharma

Sun Pharma has strategically engaged in corporate development activities, having acquired 17 companies. Notable acquisitions include Biosynthesis, Caraco Pharmaceutical Laboratories and Chattem Chemicals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Generic drugs are manufactured by Libra Merger in Israel.
2023
Immuno-oncology treatments for solid tumors are developed and commercialized.
2014
Vivaldis is engaged in providing animal healthcare solutions.
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Sun Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sun Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sun Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sun Pharma

Frequently Asked Questions about Sun Pharma

When was Sun Pharma founded?

Sun Pharma was founded in 1983.

Where is Sun Pharma located?

Sun Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

How many employees does Sun Pharma have?

As of Mar 31, 2024, the latest employee count at Sun Pharma is 25,870.

What is the annual revenue of Sun Pharma?

Annual revenue of Sun Pharma is $6.09B as on Mar 31, 2024.

What does Sun Pharma do?

Sun Pharma was founded in 1983 in Mumbai, India, as a specialty generic pharmaceutical entity. Formulations and active pharmaceutical ingredients are produced and distributed across therapeutic areas including psychiatry, neurology, cardiology, diabetology, gastroenterology, gynaecology, nephrology, urology, and oncology. Dosage forms encompass tablets, capsules, injectables, inhalers, ointments, creams, and liquids. In 2022, annual revenues reached 5.39 billion with net profits at 0.54 billion.

Is Sun Pharma publicly traded?

Yes, Sun Pharma is publicly traded on NSE under the ticker symbol SUNPHARMA.

How many acquisitions has Sun Pharma made?

Sun Pharma has made 17 acquisitions, including Biosynthesis, Caraco Pharmaceutical Laboratories, and Chattem Chemicals.

What is Sun Pharma's ticker symbol?

The ticker symbol of Sun Pharma is SUNPHARMA on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available